Treatment with Repository Corticotropin Injection in Patients with Rheumatoid Arthritis, Systemic Lupus Erythematosus, and Dermatomyositis/Polymyositis
Nancy Ho-Mahler,1 Beni Turner,2 Michael Eaddy,2 Mark L Hanke,1 Winnie W Nelson1 1Mallinckrodt Pharmaceuticals, Bedminster, NJ, USA; 2Xcenda, Palm Harbor, FL, USACorrespondence: Nancy Ho-MahlerMallinckrodt Pharmaceuticals, 1425 U.S. Route 206, Bedminster, NJ 07921, USATel +1 747 239 0007Fax +1 314 65...
Enregistré dans:
Auteurs principaux: | Ho-Mahler N, Turner B, Eaddy M, Hanke ML, Nelson WW |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/986e4a77b8e6411cb2e8470a0d405a3f |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Repository corticotropin injection in patients with refractory psoriatic arthritis: a case series
par: Brown AN
Publié: (2016) -
Repository corticotropin injection as adjunctive therapy in patients with rheumatoid arthritis who have failed previous therapies with at least three different modes of action
par: Gillis T, et autres
Publié: (2017) -
La melatonina reduce la respuesta de cortisol al ACTH en humanos
par: Campino,Carmen, et autres
Publié: (2008) -
Basal serum cortisol and adrenocorticotropic hormone levels in patients with atopic dermatitis
par: Zohreh Tehranchinia, et autres
Publié: (2017) -
El cateterismo bilateral y simultáneo de los senos petrosos inferiores en el diagnóstico diferencial del síndrome de Cushing
par: Belli,Susana, et autres
Publié: (2007)